What s Inside the Patent Portfolio that Incyte Licensed to Agilent? | GenomeWeb

• Linear amplification patents by Russell Van Gelder, James Eberwine, and others. These include not only the patents at issue in the Incyte-Affymetrix litigation, US Patent Numbers 5,716,785 and 5,891,636, but also US Patent Number 5,545, 522, “Process for amplifying a target polynucleotide sequence using a single-primer promoter complex.” These patents cover the popular T7 Eberwine protocol for linear amplification, and has already been licensed to Merck among others.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.